BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 33272192)

  • 1. Survey on neutralizing antibodies against Zika virus eighteen months post-outbreak in two southern Thailand communities.
    Densathaporn T; Sangthong R; Sakolnapa M; Surasombatpattana S; Kemapunmanus M; Masrinoul P; Yoksan S; McNeil EB; Chongsuvivatwong V
    BMC Infect Dis; 2020 Dec; 20(1):921. PubMed ID: 33272192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of Flavivirus Neutralizing Antibodies in Thailand by High-Throughput Neutralization Assay: Endemic Circulation of Zika Virus before 2012.
    Yamanaka A; Matsuda M; Okabayashi T; Pitaksajjakul P; Ramasoota P; Saito K; Fukasawa M; Hanada K; Matsuura T; Muramatsu M; Shioda T; Suzuki R
    mSphere; 2021 Aug; 6(4):e0033921. PubMed ID: 34259560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Zika virus neutralizing antibodies in healthy adults in Vietnam during and after the Zika virus epidemic season: a longitudinal population-based survey.
    Nguyen CT; Moi ML; Le TQM; Nguyen TTT; Vu TBH; Nguyen HT; Pham TTH; Le THT; Nguyen LMH; Phu Ly MH; Ng CFS; Takemura T; Morita K; Hasebe F
    BMC Infect Dis; 2020 May; 20(1):332. PubMed ID: 32393198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-Reaction, Enhancement, and Neutralization Activity of Dengue Virus Antibodies against Zika Virus: A Study in the Mexican Population.
    Montecillo-Aguado MR; Montes-Gómez AE; García-Cordero J; Corzo-Gómez J; Vivanco-Cid H; Mellado-Sánchez G; Muñoz-Medina JE; Gutiérrez-Castañeda B; Santos-Argumedo L; González-Bonilla C; Cedillo-Barrón L
    J Immunol Res; 2019; 2019():7239347. PubMed ID: 31565661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An epidemiological survey of the current status of Zika and the immune interaction between dengue and Zika infection in Southern Taiwan.
    Wang WH; Urbina AN; Wu CC; Lin CY; Thitithanyanont A; Assavalapsakul W; Lu PL; Chen YH; Wang SF
    Int J Infect Dis; 2020 Apr; 93():151-159. PubMed ID: 31982624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas.
    Montoya M; Collins M; Dejnirattisai W; Katzelnick LC; Puerta-Guardo H; Jadi R; Schildhauer S; Supasa P; Vasanawathana S; Malasit P; Mongkolsapaya J; de Silva AD; Tissera H; Balmaseda A; Screaton G; de Silva AM; Harris E
    J Infect Dis; 2018 Jul; 218(4):536-545. PubMed ID: 29618091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Zika virus neutralizing antibodies in normal healthy Thais.
    Sornjai W; Jaratsittisin J; Auewarakul P; Wikan N; Smith DR
    Sci Rep; 2018 Nov; 8(1):17193. PubMed ID: 30464242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zika Virus Antibody Titers Three Years after Confirmed Infection.
    Langerak T; Kasbergen LMR; Chandler F; Brinkman T; Faerber Z; Phalai K; Ulbert S; Rockstroh A; Bruin E; Koopmans MPG; Rockx B; van Gorp ECM; Vreden S
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zika Virus Seroprevalence in Urban and Rural Areas of Suriname, 2017.
    Langerak T; Brinkman T; Mumtaz N; Arron G; Hermelijn S; Baldewsingh G; Wongsokarijo M; Resida L; Rockx B; Koopmans MPG; Van Gorp ECM; Vreden S
    J Infect Dis; 2019 Jun; 220(1):28-31. PubMed ID: 30753538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological evidence of DENV, JEV, and ZIKV among the indigenous people (Orang Asli) of Peninsular Malaysia.
    Khor CS; Mohd-Rahim NF; Hassan H; Tan KK; Zainal N; Teoh BT; Sam SS; Khoo JJ; Lee HY; Lim YA; Abubakar S
    J Med Virol; 2020 Aug; 92(8):956-962. PubMed ID: 31814135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of dengue, Japanese encephalitis and Zika among long-term expatriates in Thailand.
    Kitro A; Imad HA; Pisutsan P; Matsee W; Sirikul W; Sapbamrer R; Rapheal E; Fernandez S; Cotrone TS; Farmer AR; Hunsawong T; Silachamroon U; Chatapat L; Olanwijitwong J; Salee P; Anderson KB; Piyaphanee W
    J Travel Med; 2024 Mar; 31(2):. PubMed ID: 38335250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of Dengue, Zika, and Chikungunya Viruses in Wild Monkeys in Thailand.
    Tongthainan D; Mongkol N; Jiamsomboon K; Suthisawat S; Sanyathitiseree P; Sukmak M; Wajjwalku W; Poovorawan Y; Ieamsaard G; Sangkharak B; Taruyanon K; Fungfuang W; Tulayakul P; Boonnak K
    Am J Trop Med Hyg; 2020 Sep; 103(3):1228-1233. PubMed ID: 32588813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Zika Virus Seroprevalence in Salvador, Northeastern Brazil Limits the Potential for Further Outbreaks.
    Netto EM; Moreira-Soto A; Pedroso C; Höser C; Funk S; Kucharski AJ; Rockstroh A; Kümmerer BM; Sampaio GS; Luz E; Vaz SN; Dias JP; Bastos FA; Cabral R; Kistemann T; Ulbert S; de Lamballerie X; Jaenisch T; Brady OJ; Drosten C; Sarno M; Brites C; Drexler JF
    mBio; 2017 Nov; 8(6):. PubMed ID: 29138300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporation of IgG Depletion in a Neutralization Assay Facilitates Differential Diagnosis of Zika and Dengue in Secondary Flavivirus Infection Cases.
    Calvert AE; Boroughs KL; Laven J; Stovall JL; Luy BE; Kosoy OI; Huang CY
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29618505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perinatal analyses of Zika- and dengue virus-specific neutralizing antibodies: A microcephaly case-control study in an area of high dengue endemicity in Brazil.
    Castanha PMS; Souza WV; Braga C; Araújo TVB; Ximenes RAA; Albuquerque MFPM; Montarroyos UR; Miranda-Filho DB; Cordeiro MT; Dhalia R; Marques ETA; Rodrigues LC; Martelli CMT;
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007246. PubMed ID: 30856223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Anti-Dengue and Anti-Zika IgG on a Plasmonic Gold Platform with Neutralization Testing.
    Rojas A; Natrajan MS; Weber J; Cardozo F; Cantero C; Ananta JS; Kost J; Tang M; López S; Bernal C; Guillén Y; Mendoza L; Páez M; Pinsky BA; Waggoner JJ
    Am J Trop Med Hyg; 2021 Mar; 104(5):1729-1733. PubMed ID: 33782214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated exposure to dengue virus elicits robust cross neutralizing antibodies against Zika virus in residents of Northeastern Thailand.
    Hattakam S; Elong Ngono A; McCauley M; Shresta S; Yamabhai M
    Sci Rep; 2021 May; 11(1):9634. PubMed ID: 33953258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.
    Swanstrom JA; Plante JA; Plante KS; Young EF; McGowan E; Gallichotte EN; Widman DG; Heise MT; de Silva AM; Baric RS
    mBio; 2016 Jul; 7(4):. PubMed ID: 27435464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of Japanese encephalitis virus antibodies on Zika virus infection.
    He X; Lang X; Yu J; Zhu L; Qin Z; Liu X; Chen P; Dai C; Chen T; Li X; Chen Y; Zhou D; Fang W; Xiao W; Zhang B; Xie Q; Wu Q; Zhao W
    Med Microbiol Immunol; 2020 Apr; 209(2):177-188. PubMed ID: 32078028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological evidence of Zika virus infection in non-human primates in Zambia.
    Wastika CE; Sasaki M; Yoshii K; Anindita PD; Hang'ombe BM; Mweene AS; Kobayashi S; Kariwa H; Carr MJ; Hall WW; Eshita Y; Orba Y; Sawa H
    Arch Virol; 2019 Aug; 164(8):2165-2170. PubMed ID: 31154511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.